Pharmaceutical Resources (PRX)

[mlkrborn]

Avanir Pharmaceuticals files lawsuits against Par (PRX) and Actavis for infringement of NUEDEXTA patents (AVNR) 2.70 : Co announced that it has filed lawsuits in the U.S. District Court for the District of Delaware against Par Pharmaceutical (PRX) amd Actavis South Atlantic LLC and Actavis. The lawsuits were filed in response to Abbreviated New Drug Applications filed by Par and Actavis. In their applications, Par and Actavis seek to market and sell generic versions of the currently approved dose of NUEDEXTA prior to the expiration of U.S. patents. Avanir filed the lawsuits on the basis that Par's and Actavis' proposed generic products infringe certain patents held by Avanir.